Torrent Pharmaceuticals Limited
NSE: TORNTPHARM BSE: TORNTPHARM
NSE
3,576.50
-19.90 (-0.55%)
Prev Close
3596.4
Open Price
3599.8
Volume
133,893
Today Low / High
3552.9 / 3602.5
52 WK Low / High
2886.45 / 3787.9
Range
3,398 - 3,755
BSE
3,578.10
-17.50 (-0.49%)
Prev Close
3595.6
Open Price
3566.5
Volume
1,899
Today Low / High
3553.95 / 3599.05
52 WK Low / High
2891.45 / 3790
Range
3,399 - 3,757
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 3576.5 (target range: 3,398 - 3,755), reflecting a change of -19.9 (-0.55333%). On the BSE, it is listed at 3578.1 (target range: 3,399 - 3,757), showing a change of -17.5 (-0.48671%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
28 Oct
3,599.80
-0.65%
27 Oct
3,584.00
0.35%
24 Oct
3,634.60
-1.46%
23 Oct
3,572.00
1.18%
21 Oct
3,571.00
0.56%
20 Oct
3,584.90
-0.40%
17 Oct
3,533.80
1.43%
16 Oct
3,535.00
-0.03%
15 Oct
3,520.30
0.36%
14 Oct
3,520.00
0.06%
13 Oct
3,515.00
0.09%
10 Oct
3,550.50
-0.50%
09 Oct
3,580.00
-0.82%
08 Oct
3,537.00
0.90%
07 Oct
3,540.80
-0.11%
06 Oct
3,514.70
0.32%
03 Oct
3,552.00
-1.05%
01 Oct
3,603.10
-1.00%
30 Sep
3,599.00
0.12%
Torrent Pharmaceuticals Limited Graph
Torrent Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Torrent Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3,576.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 3,578.10 | 3,613.88 | 3,252.49 - 3,975.27 |
| 3,649.66 | 2,919.73 - 4,379.59 | ||
| 3,685.44 | 2,579.81 - 4,791.08 | ||
| Bearish Scenario | 3,578.10 | 3,542.32 | 3,188.09 - 3,896.55 |
| 3,506.54 | 2,805.23 - 4,207.85 | ||
| 3,470.76 | 2,429.53 - 4,511.98 |
Overview of Torrent Pharmaceuticals Limited
ISIN
INE685A01028
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
276,675
Market Cap
1,210,448,542,500
Last Dividend
32
Official Website
IPO Date
2002-07-01
DCF Diff
-6,258.13
DCF
9,936
Financial Ratios Every Investor Needs
Stock Dividend of TORNTPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-06-20 | June 20, 25 | 6 | 6 | 2025-06-20 | 2025-08-04 | |
| 2025-01-31 | January 31, 25 | 26 | 26 | 2025-02-01 | 2025-02-17 | |
| 2024-06-21 | June 21, 24 | 6 | 6 | 2024-06-21 | 2024-08-22 | |
| 2024-02-12 | February 12, 24 | 22 | 22 | 2024-02-12 | 2024-03-03 | |
| 2023-06-23 | June 23, 23 | 8 | 8 | 2023-06-23 | 2023-09-06 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11,516.09 Cr | 2,775.90 Cr | 8,740.19 Cr | 0.7590 | 581.00 Cr | 738.22 Cr | 5,888.35 Cr | 1,911.00 Cr | 56.47 | 3,675.82 Cr | 0.1659 |
| 2024-03-31 | 10,727.84 Cr | 2,686.21 Cr | 8,041.63 Cr | 0.7496 | 527.00 Cr | 772.28 Cr | 5,497.99 Cr | 1,656.38 Cr | 48.94 | 3,324.90 Cr | 0.1544 |
| 2023-03-31 | 9,620.15 Cr | 2,735.19 Cr | 6,884.96 Cr | 0.7157 | 516.00 Cr | 613.76 Cr | 4,663.78 Cr | 1,245.23 Cr | 36.79 | 2,802.64 Cr | 0.1294 |
| 2022-03-31 | 8,508.04 Cr | 2,442.01 Cr | 6,066.03 Cr | 0.7130 | 516.00 Cr | 554.88 Cr | 4,001.74 Cr | 777.18 Cr | 22.96 | 2,382.31 Cr | 0.0913 |
| 2021-03-31 | 8,004.57 Cr | 2,146.42 Cr | 5,858.15 Cr | 0.7319 | 487.00 Cr | 565.66 Cr | 3,911.46 Cr | 1,251.88 Cr | 36.99 | 2,429.05 Cr | 0.1564 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 579.00 Cr | 14,990.00 Cr | 7,399.00 Cr | 7,591.0000 Cr | 3,202.00 Cr | 2,623.00 Cr | 2,541.00 Cr | 3,822.00 Cr | 0.00 Cr | 0.46 Cr | 57.06 Cr | 4,717.0000 Cr |
| 2024-03-31 | 835.14 Cr | 15,060.58 Cr | 8,204.43 Cr | 6,856.1500 Cr | 4,021.94 Cr | 3,186.80 Cr | 2,279.07 Cr | 3,577.77 Cr | 4.50 Cr | 0.96 Cr | 72.00 Cr | 5,425.2500 Cr |
| 2023-03-31 | 508.00 Cr | 15,012.00 Cr | 8,814.00 Cr | 6,198.0000 Cr | 5,368.00 Cr | 4,860.00 Cr | 2,230.00 Cr | 3,460.00 Cr | 846.00 Cr | 1.46 Cr | 73.61 Cr | 5,447.0000 Cr |
| 2022-03-31 | 398.40 Cr | 13,099.84 Cr | 7,146.89 Cr | 5,952.9500 Cr | 4,069.65 Cr | 3,671.25 Cr | 2,462.32 Cr | 3,246.93 Cr | 732.04 Cr | 1.96 Cr | 94.27 Cr | 4,415.0900 Cr |
| 2021-03-31 | 572.56 Cr | 14,074.65 Cr | 8,237.48 Cr | 5,837.1700 Cr | 4,874.13 Cr | 4,301.57 Cr | 2,681.20 Cr | 3,628.75 Cr | 785.95 Cr | 3.30 Cr | -97.33 Cr | 4,891.6200 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,585.0000 Cr | -540.0000 Cr | -2,298.0000 Cr | 1,974.0000 Cr | -262.1400 Cr | 573.0000 Cr | -611.0000 Cr | 1,911.0000 Cr | -925.5000 Cr | -1,083.0000 Cr | -262.0000 Cr |
| 2024-03-31 | 3,266.0800 Cr | -167.9000 Cr | -2,779.6400 Cr | 2,833.3000 Cr | 326.6100 Cr | 835.1400 Cr | -432.7800 Cr | 1,656.3800 Cr | -1,369.4400 Cr | -1,015.3400 Cr | -49.0000 Cr |
| 2023-03-31 | 2,368.0000 Cr | -2,415.0000 Cr | 77.0000 Cr | 1,794.0000 Cr | 110.0000 Cr | 508.0000 Cr | -574.0000 Cr | 1,847.0000 Cr | 1,265.1900 Cr | -863.0400 Cr | 256.0000 Cr |
| 2022-03-31 | 1,802.9900 Cr | -196.6300 Cr | -1,781.0500 Cr | 1,600.4200 Cr | -174.1600 Cr | 398.4000 Cr | -202.5700 Cr | 1,225.9100 Cr | -814.3400 Cr | -676.8900 Cr | 218.8800 Cr |
| 2021-03-31 | 2,010.6900 Cr | -449.4200 Cr | -1,656.1300 Cr | 1,675.5400 Cr | -89.2600 Cr | 572.5600 Cr | -335.1500 Cr | 1,526.2600 Cr | -921.8300 Cr | -338.4500 Cr | -532.9800 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 3,178.00 Cr | 774.00 Cr | 2,404.00 Cr | 0.7565 | 1,642.00 Cr | 548.00 Cr | 16.19 | 1,018.44 Cr | 0.1724 |
| 2025-03-31 | 2,959.09 Cr | 730.90 Cr | 2,228.19 Cr | 0.7530 | 1,449.35 Cr | 498.00 Cr | 14.71 | 950.50 Cr | 0.1683 |
| 2024-12-31 | 2,809.00 Cr | 673.00 Cr | 2,136.00 Cr | 0.7604 | 1,436.00 Cr | 503.00 Cr | 14.88 | 903.14 Cr | 0.1791 |
| 2024-09-30 | 2,889.00 Cr | 678.00 Cr | 2,211.00 Cr | 0.7653 | 1,523.00 Cr | 453.00 Cr | 13.37 | 938.50 Cr | 0.1568 |
| 2024-06-30 | 2,859.00 Cr | 694.00 Cr | 2,165.00 Cr | 0.7573 | 1,480.00 Cr | 457.00 Cr | 13.50 | 915.14 Cr | 0.1598 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 687.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7,590.69 Cr |
| 2025-03-31 | 579.00 Cr | 114.49 Cr | 691.00 Cr | 1,867.00 Cr | 2,541.00 Cr | 5,623.00 Cr | 3,822.00 Cr | 14,990.00 Cr | 7,399.00 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1,235.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -7,504.00 Cr |
| 2024-09-30 | 1,146.00 Cr | 85.00 Cr | 1,235.00 Cr | 1,787.00 Cr | 2,271.00 Cr | 5,879.00 Cr | 3,629.00 Cr | 15,088.00 Cr | 7,584.00 Cr |
| 2024-06-30 | -1,004.00 Cr | 2,008.00 Cr | 1,004.00 Cr | 0.00 Cr | 0.00 Cr | 1,004.00 Cr | 0.00 Cr | 0.00 Cr | -6,856.15 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 548.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 498.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 503.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 453.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 457.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-07-08 | July 08, 22 | 2:1 |
| 2013-07-23 | July 23, 13 | 2:1 |
| 2006-02-20 | February 20, 06 | 2:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,687.00 | ₹4,047,671,982,389.00 | ₹2,440,907.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,438.50 | ₹1,709,224,809,162.00 | ₹305,872.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,576.50 | ₹1,210,448,542,500.00 | ₹133,893.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,289.40 | ₹1,073,250,238,305.00 | ₹1,828,269.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,001.25 | ₹1,007,487,347,951.00 | ₹382,044.00 |
| Mankind Pharma Limited | MANKIND | ₹2,406.50 | ₹993,303,306,185.00 | ₹271,023.00 |
| Lupin Limited | LUPIN | ₹1,918.70 | ₹876,381,321,332.00 | ₹668,996.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,432.00 | ₹649,477,080,000.00 | ₹156,752.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,099.40 | ₹638,533,304,326.00 | ₹1,130,406.00 |
| Laurus Labs Limited | LAURUSLABS | ₹959.65 | ₹518,042,964,325.00 | ₹2,714,923.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,815.10 | ₹512,222,688,416.00 | ₹339,123.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹859.70 | ₹328,892,970,258.00 | ₹338,239.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,285.90 | ₹326,238,253,926.00 | ₹63,010.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,388.40 | ₹298,396,244,362.00 | ₹56,805.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,686.00 | ₹264,021,258,954.00 | ₹36,351.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,326.00 | ₹251,362,987,122.00 | ₹89,776.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,315.50 | ₹232,887,500,000.00 | ₹17,491.00 |
| Eris Lifesciences Limited | ERIS | ₹1,628.40 | ₹221,810,151,334.00 | ₹201,101.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,296.90 | ₹210,726,538,417.00 | ₹240,869.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,740.00 | ₹201,942,452,860.00 | ₹26,058.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹905.60 | ₹178,007,565,094.00 | ₹64,648.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,122.00 | ₹177,893,979,648.00 | ₹220,240.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,012.00 | ₹152,935,532,352.00 | ₹30,388.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹826.50 | ₹148,034,307,555.00 | ₹240,008.00 |
| Granules India Limited | GRANULES | ₹569.95 | ₹138,309,034,684.00 | ₹457,943.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹905.95 | ₹111,143,167,221.00 | ₹89,266.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,183.00 | ₹102,633,978,906.00 | ₹5,459.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹843.00 | ₹76,403,592,867.00 | ₹103,602.00 |
| Strides Pharma Science Limited | STAR | ₹814.00 | ₹75,028,589,196.00 | ₹168,130.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹361.10 | ₹70,624,593,758.00 | ₹144,078.00 |
| FDC Limited | FDC | ₹432.05 | ₹70,342,096,792.00 | ₹151,149.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹457.20 | ₹69,998,260,918.00 | ₹100,352.00 |
| Sequent Scientific Limited | SEQUENT | ₹206.17 | ₹51,524,532,078.00 | ₹1,087,872.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹460.00 | ₹50,124,021,900.00 | ₹1,023,719.00 |
| Innova Captab Limited | INNOVACAP | ₹809.85 | ₹46,343,608,751.00 | ₹13,089.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.23 | ₹46,156,705,461.00 | ₹7,842,918.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹481.10 | ₹43,909,997,000.00 | ₹215,251.00 |
| Suven Life Sciences Limited | SUVEN | ₹194.00 | ₹42,299,895,218.00 | ₹85,389.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,377.50 | ₹39,321,508,163.00 | ₹8,656.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹703.85 | ₹35,698,642,054.00 | ₹75,131.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹337.35 | ₹33,830,303,399.00 | ₹45,042.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹465.55 | ₹32,777,396,913.00 | ₹10,150.00 |
Key Executives
Chief Customer Service Officer
Mr. Abdullah Salam Said Al Abri
Gender: male
Year Born:
President and Chief Executive Officer of Torrent Pharma USA
Mr. Sanjay Gupta
Gender: male
Year Born:
Whole-Time Director
Mr. Aman Mehta
Gender: male
Year Born:
Company Secretary & Compliance Officer
Mr. Chintan M. Trivedi
Gender: male
Year Born:
Executive Chairman & MD
Mr. Samir Uttamlal Mehta B.Com., MBA
Gender: male
Year Born: 1963
Chief Financial Officer
Mr. Sudhir Menon CA, CWA
Gender: male
Year Born: 1972
Vice President of Human Resource
Mr. Jaydip Bhatt
Gender: male
Year Born: 1953
Executive Director
Mr. Ashish Hajarnish M.Pharm
Gender: male
Year Born: 1968
FAQs about Torrent Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Sanjay Gupta.
What is the current market price of the stock?
The current price is ₹3,576.50.
What is the 52-week price range?
The range is ₹2886.45-3787.9.
What is the market capitalization of the company?
The market capitalization is ₹121,044.85 crores.
What is the dividend yield?
The dividend yield is 0.89%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 60.47.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Torrent Pharmaceuticals Limited (ISIN: INE685A01028) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹121,044.85 crores and an average daily volume of 276,675 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹32.